Bowei Li
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Atherosclerosis and Cardiovascular Diseases
- Galectins and Cancer Biology
Papers in
- Surgery 7
- Helicobacter pylori-related gastroenterology studies 2
- Co-authors
- Yuanpeng Xia (5 shared papers)Bo Hu (2 shared papers)Ling Mao (4 shared papers)Xueying Luo (4 shared papers)Shengcai Chen (3 shared papers)Yanan Li (2 shared papers)Huijuan Jin (2 shared papers)Zi‐Ming Ye (2 shared papers)
In The Last Decade
Bowei Li
22 papers receiving 578 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 167
- Immunology 202
- Biological Psychiatry 11
- Molecular Biology 277
- Neurology 29
Countries citing papers authored by Bowei Li
This map shows the geographic impact of Bowei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bowei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bowei Li more than expected).
Fields of papers citing papers by Bowei Li
This network shows the impact of papers produced by Bowei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bowei Li. The network helps show where Bowei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Bowei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 162 | |
| 2 | 2020 | 106 | |
| 3 | 2019 | 67 | |
| 4 | 2023 | 45 | |
| 5 | 2017 | 41 | |
| 6 | 2018 | 33 | |
| 7 | 2017 | 18 | |
| 8 | 2021 | 18 | |
| 9 | 2024 | 14 | |
| 10 | 2023 | 11 | |
| 11 | 2018 | 10 | |
| 12 | Hypertensive vascular remodeling was inhibited by Xuezhikang through the regulation of Fibulin-3 and MMPs in spontaneously hypertensive rats. | 2015 | 10 |
| 13 | 2020 | 9 | |
| 14 | 2020 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2025 | 4 | |
| 17 | 2016 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2025 | 3 | |
| 20 | 2024 | 3 |
About Bowei Li
Bowei Li is a scholar working on Surgery, Molecular Biology, Immunology, Epidemiology and Cellular and Molecular Neuroscience, having authored 25 papers that have together received 582 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Peptidase Inhibition and Analysis (3 papers), Alzheimer's disease research and treatments (2 papers), Galectins and Cancer Biology (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Cancer Research (167 citations), Immunology (202 citations), Biological Psychiatry (11 citations), Molecular Biology (277 citations) and Neurology (29 citations). Bowei Li has collaborated with scholars based in China, Tunisia and Spain. Frequent co-authors include Yuanpeng Xia, Bo Hu, Ling Mao, Xueying Luo, Shengcai Chen, Yanan Li, Huijuan Jin, Zi‐Ming Ye, Chao Qin and Shuai Yang. Their work appears in journals such as Cellular and Molecular Life Sciences, The FASEB Journal, Journal of Molecular and Cellular Cardiology, Frontiers in Cell and Developmental Biology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.